Table 1 General characteristics of the patients.

From: Current treatments for endometriosis in South Korea: an analysis of nationwide data from 2010 to 2019

Year (n)

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

(602)

(639)

(651)

(660)

(711)

(721)

(797)

(809)

(897)

(1043)

Age group (%)

 0–19

13 (2.2)

10 (1.6)

8 (1.2)

13 (2.0)

8 (1.1)

12 (1.7)

11 (1.4)

9 (1.1)

9 (1.0)

15 (1.4)

 20–29

162 (26.9)

177 (27.7)

165 (25.3)

149 (22.6)

191 (26.9)

178 (24.7)

206 (25.8)

220 (27.2)

237 (26.4)

264 (25.3)

 30–39

225 (37.4)

245 (38.3)

276 (42.4)

279 (42.3)

285 (40.1)

274 (38.0)

290 (36.4)

340 (42.0)

326 (36.3)

394 (37.8)

 40–49

168 (27.9)

172 (26.9)

168 (25.8)

186 (28.2)

208 (29.3)

222 (30.8)

248 (31.1)

204 (25.2)

273 (30.4)

305 (29.3)

 50–59

27 (4.5)

28 (4.4)

29 (4.5)

29 (4.4)

15 (2.1)

32 (4.4)

35 (4.4)

34 (4.2)

44 (4.9)

54 (5.2)

 ≥ 60

7 (1.2)

7 (1.1)

5 (0.8)

4 (0.6)

4 (0.6)

3 (0.4)

7 (0.9)

2 (0.2)

8 (0.9)

10 (1.0)

Infertility

37 (6.1)

57 (8.9)

49 (7.5)

46 (7.0)

48 (6.8)

50 (6.9)

38 (4.8)

50 (6.2)

42 (4.7)

45 (4.3)

Pelvic pain

152 (25.2)

177 (27.7)

158 (24.3)

165 (25.0)

191 (26.9)

200 (27.7)

194 (24.3)

249 (30.8)

263 (29.3)

328 (31.4)

Unspecified dysmenorrhea

47 (7.8)

50 (7.8)

59 (9.1)

66 (10.0)

77 (10.8)

69 (9.6)

98 (12.3)

103 (12.7)

82 (9.1)

107 (10.3)

Secondary dysmenorrhea

19 (3.2)

15 (2.3)

20 (3.1)

19 (2.9)

14 (2.0)

12 (1.7)

29 (3.6)

25 (3.1)

28 (3.1)

24 (2.3)

Uterine fibroids

110 (18.3)

119 (18.6)

124 (19.0)

131 (19.8)

135 (19.0)

164 (22.7)

186 (23.3)

163 (20.1)

184 (20.5)

205 (19.7)

Adenomyosis

93 (15.4)

82 (12.8)

68 (10.4)

75 (11.4)

82 (11.5)

96 (13.3)

105 (13.2)

102 (12.6)

105 (11.7)

130 (12.5)

  1. General characteristics of the patients were presented with numbers and percentages.